Skip to main content
logo
Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.800
-0.100 (-5.26%)
Aug 5, 2026, 1:20 PM EDT - Market open

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Cap
164--
Market Cap Growth
-85.98%61.50%---
Enterprise Value
0.372.057.0200
Last Close Price
1.8019.20301.50--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
2.222.31-0.93--
P/TBV Ratio
1.250.98---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
6.200.71-1.090.00-
Net Debt / Equity Ratio
-1.46-1.52-0.830.29-
Net Debt / EBITDA Ratio
0.040.34-0.260.95-
Net Debt / FCF Ratio
0.040.37-0.390.97-
Quick Ratio
0.592.170.342.09-
Current Ratio
1.002.410.642.27-
Return on Equity (ROE)
-703.32%1718.90%169.73%66.01%-
Return on Assets (ROA)
-168.98%-230.90%-309.86%-179.24%-
Return on Invested Capital (ROIC)
---1048.22%-153.94%-
Return on Capital Employed (ROCE)
-399.36%-612.69%-1047.58%-305.95%-
SEC Filings: 10-K · 10-Q